Target intelligence / Profile preview

Immunoglobulin kappa variable 3D-34 (IGKV3D-34)

Target
IGKV3D-34
Molecular classification
Other
01

Overview

Immunoglobulin kappa variable 3D-34 refers to a pseudogene of the immunoglobulin kappa variable (IGKV) gene family, specifically the 3D-34 variant. Immunoglobulin kappa variable genes are responsible for encoding the variable domain of the kappa light chain of immunoglobulins (antibodies), which play a fundamental role in antigen recognition as part of the adaptive immune response. However, IGKV3D-34 is designated as a pseudogene, meaning it is a non-functional DNA segment that resembles a gene but typically does not encode a functional protein product, nor does it serve as a direct therapeutic target[1][3]. Key points: - The IGKV gene family includes many functional genes and pseudogenes, located in clusters within the immunoglobulin kappa locus[3]. - "3D-34" identifies a specific pseudogene within the IGKV3 subgroup (distal cluster), but there is no evidence that IGKV3D-34 encodes a functional protein. - Pseudogenes such as IGKV3D-34 are not typically considered direct therapeutic targets, nor do they interact with drugs or have documented roles as clinical biomarkers. - Information for related functioning genes such as IGKV3-11 indicates that active immunoglobulin kappa variable genes participate in antigen binding and immune response, but the pseudogene IGKV3D-34 itself does not contribute directly due to its lack of protein expression[4]. Summary: IGKV3D-34 is a nonfunctional immunoglobulin gene pseudogene, not a therapeutic target, enzyme, receptor, or transporter, and it is designated "incorrect" for most therapeutic target applications due to its pseudogene status[1][3].

Other names
IGKV3D-34 (pseudogene)
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Immunoglobulin kappa variable 3D-34 (IGKV3D-34).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 3D-34 (IGKV3D-34).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call